You can wear a patch to quit smoking, a patch to fend of pregnancy, and pretty soon, youll be able to wear a patch to treat depression.
Emsam, an experimental skin patch received U.S. regulatory approval for treating major depression in adults, Somerset Pharmaceuticals Inc. and Bristol-Myers Squibb announced on Tuesday.
The patch transmits monoamine oxidase inhibitors, a type of antidepressant, through the skin. These types of drugs have been approved by the FDA and carry warnings about risks...
Read moreTwo weeks ago we told you that the 25mcg/hr fentanyl transdermal system patches (also known as Duragesic patches) were being recalled due... Read more »
Watson Pharmaceuticals, Inc. announced Tuesday that one lot of 100 mcg/hr Fentanyl Transdermal System patches sold in the U.S. is being... Read more »
While fentanyl patches can be very effective for relieving chronic pain, sometimes keeping them from falling off presents quite a... Read more »
I've developed a rash recently and I don't know if it's eczema or just a skin allergy. I changed detergents recently. Does this have... Read more »
On Monday, Novartis, a pharmaceutical giant, received U.S. approval for the Exelon Patch, which delivers a treatment for Alzheimer's... Read more »
The FDA has approved EMSAM (selegiline), a transdermal patch, for the treatment of major depression. Selegeline is a MAOI originally used to treat... Read more »
You can wear a patch to quit smoking and a patch to fend of pregnancy. Pretty soon, youll be able to wear a patch to treat depression. Emsam, an... Read more »
The Food and Drug Administration has approved a new generic fentanyl patch for the management of chronic pain. The patch is designed to be used twice... Read more »
The U.S. Food and Drug Administration (FDA) and drugmaker Actavis Inc. have announced that about one million fentanyl patches used to treat such... Read more »
The beginning of summer kicks off the camping and hiking season, anxiously awaited by those who have endured a long cold winter. This year will... Read more »